AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2020
Jul 7, 2020
32566_dirs_2020-07-07_6d9a855b-27ec-44a5-8c27-dd4ad95122f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2020-06-30
Reporting Person: Riggsbee Richard Bryan (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-17 | Common Stock | G | 2000 | $29.91 | Disposed | 142204 | Direct |
| 2019-10-22 | Common Stock | G | 500 | $30.39 | Disposed | 141704 | Direct |
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2